Asia Pacific Cat Vaccine Market

Asia Pacific Cat Vaccine Market Size, Share & Trends Analysis Report By Component, By Route of Administration (Injectables, Intranasal, and Oral), By Duration of Immunity, By Disease Type, By Type, By Country and Growth Forecast, 2024 - 2031

Report Id: KBV-23573 Publication Date: July-2024 Number of Pages: 136
Special Offering:
Industry Insights | Market Trends
Highest number of Tables | 24/7 Analyst Support

Analysis of Market Size & Trends

The Asia Pacific Cat Vaccine Market would witness market growth of 9.8% CAGR during the forecast period (2024-2031).

The China market dominated the Asia Pacific Cat Vaccine Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $175.1 million by 2031. The Japan market is registering a CAGR of 9.3% during (2024 - 2031). Additionally, The India market would showcase a CAGR of 10.6% during (2024 - 2031).

Asia Pacific Cat Vaccine Market

In developing countries, where awareness and access to veterinary care can be more limited, international organizations and NGOs play a crucial role in education and outreach. For instance, in India, the World Veterinary Association (WVA) and local organizations like the Indian Veterinary Association (IVA) work to increase awareness about pet health. In rural areas, where veterinary services are frequently unavailable, they conduct vaccination initiatives and educational campaigns. These efforts include door-to-door campaigns, community meetings, and the distribution of educational pamphlets in local languages, which have been effective in raising awareness and increasing vaccination rates.

Advancements in veterinary medicine have also played a crucial role in expanding the market. Continuous research and development have led to more effective and safer vaccines. Innovations such as combination vaccines, which protect against multiple diseases with a single injection, have streamlined the vaccination process for veterinarians and pet owners. These advancements improve cat health outcomes and enhance the vaccination experience, making it more convenient and less stressful for pets and their owners.

The influence of social media cannot be underestimated in India's context. Veterinarians and animal rights activists use platforms like Facebook, Instagram, and YouTube to disseminate information about pet health and vaccinations. Prominent figures such as Maneka Gandhi, a well-known animal rights advocate, frequently discuss pet care and the necessity of vaccinations in her public addresses and social media posts. Her advocacy helps reach a wide audience, boosting awareness and acceptance of vaccination practices. Therefore, the region will present lucrative growth opportunities for market growth.

Free Valuable Insights: The Global Cat Vaccine Market is Predict to reach USD 2.5 Billion by 2031, at a CAGR of 9.2%

Based on Component, the market is segmented into Combined Vaccines, and Mono Vaccines. Based on Route of Administration, the market is segmented into Injectables, Intranasal, and Oral. Based on Duration of Immunity, the market is segmented into 1 Year, 3 Year, and Others. Based on Disease Type, the market is segmented into Feline Respiratory Diseases, Feline Rabies, Feline Panleukopenia (Feline Distemper), Feline Leukemia, and Others. Based on Type, the market is segmented into Modified/Attenuated Live, Inactivated (Killed), and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

Need a report that reflects how COVID-19 has impacted this market and its growth? Download Free Sample Now

List of Key Companies Profiled

  • Zoetis, Inc.
  • Elanco Animal Health, Inc.
  • Merck & Co., Inc.
  • Boehringer Ingelheim International GmbH
  • Covetrus, Inc. (Clayton, Dubilier & Rice, LLC)
  • Virbac
  • Heska Corporation (Antech Diagnostics, Inc)
  • Ceva Sante Animale
  • Bioveta, a.s.

Asia Pacific Cat Vaccine Market Report Segmentation

By Component

  • Combined Vaccines
  • Mono Vaccines

By Route of Administration

  • Injectables
  • Intranasal
  • Oral

By Duration of Immunity

  • 1 Year
  • 3 Year
  • Others

By Disease Type

  • Feline Respiratory Diseases
  • Feline Rabies
  • Feline Panleukopenia (Feline Distemper)
  • Feline Leukemia
  • Others

By Type

  • Modified/Attenuated Live
  • Inactivated (Killed)
  • Others

By Country

  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale

Trusted by over
5000+ clients

Our team of dedicated experts can provide you with attractive expansion opportunities for your business.

Client Logo